N.C. gets $570,000 in drug marketing settlement
RALEIGH (AP) — North Carolina's attorney general says the state will recover more than $570,000 from a pharmaceutical company over allegations of improper marketing.
Attorney General Roy Cooper said in a statement Monday that Brisbane, Calif.-based InterMune Inc. has agreed to pay the sum to North Carolina as part of a $37 million national settlement.
The deal addresses allegations that the company marketed the drug Actimmune to treat a condition that harms lung tissue, despite the medication not being approved for that use by the federal Food and Drug Administration.
The settlement will compensate Medicaid and other health programs that paid for the unapproved use of the drug.
In the last decade, North Carolina's Medicaid Investigations Unit has recovered more than $361 million in various cases.
Search News-Record.com
closeSearch News & Record Article Archives
Not all of the newspaper's content appears online.
*There is a fee for downloading some older articles.
